Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program

Overview of attention for article published in BMC Cancer, January 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 37 Dimensions

Readers on

mendeley: 80 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 2,898 followers.

Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program https://t.co/rT17slBiCF #hvhebron #onco #ScientiaVH @BMC_series https://t.co/ZlJZqCDwRG

12 Feb 2019

Reply Repost Favourite

Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program https://t.co/725PBQLqXy

09 Jan 2019

Reply Repost Favourite

Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program https://t.co/VDrdidqbgZ #hvhebron #onco @BMC_series [Text complet]

08 Jan 2019

Reply Repost Favourite